| Year |
Citation |
Score |
| 2020 |
Lin HH, Robertson KL, Bisbee HA, Farkas ME. Oncogenic and Circadian Effects of Small Molecules Directly and Indirectly Targeting the Core Circadian Clock. Integrative Cancer Therapies. 19: 1534735420924094. PMID 32493076 DOI: 10.1177/1534735420924094 |
0.302 |
|
| 2018 |
Jiang Y, Hardie J, Liu Y, Ray M, Luo X, Das R, Landis RF, Farkas M, Rotello VM. Nanocapsule-mediated cytosolic siRNA delivery for anti-inflammatory treatment. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29883695 DOI: 10.1016/J.Jconrel.2018.06.001 |
0.312 |
|
| 2018 |
Joshi BP, Hardie J, Farkas ME. Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 29543990 DOI: 10.1002/Chem.201706180 |
0.348 |
|
| 2016 |
Aanei IL, ElSohly AM, Farkas ME, Netirojjanakul C, Regan M, Murphy ST, O'Neil JP, Seo Y, Francis MB. Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models. Molecular Pharmaceutics. PMID 27611245 DOI: 10.1021/Acs.Molpharmaceut.6B00566 |
0.596 |
|
| 2015 |
ElSohly AM, Netirojjanakul C, Aanei IL, Jager A, Bendall S, Farkas ME, Nolan GP, Francis MB. Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-based Cell Targeting. Bioconjugate Chemistry. PMID 26076186 DOI: 10.1021/Acs.Bioconjchem.5B00226 |
0.572 |
|
| 2013 |
Farkas ME, Aanei IL, Behrens CR, Tong GJ, Murphy ST, O'Neil JP, Francis MB. PET Imaging and biodistribution of chemically modified bacteriophage MS2. Molecular Pharmaceutics. 10: 69-76. PMID 23214968 DOI: 10.1021/Mp3003754 |
0.659 |
|
| 2012 |
Carrico ZM, Farkas ME, Zhou Y, Hsiao SC, Marks JD, Chokhawala H, Clark DS, Francis MB. N-Terminal labeling of filamentous phage to create cancer marker imaging agents. Acs Nano. 6: 6675-80. PMID 22830952 DOI: 10.1021/Nn301134Z |
0.587 |
|
| 2009 |
Farkas ME, Li BC, Dose C, Dervan PB. DNA sequence selectivity of hairpin polyamide turn units. Bioorganic & Medicinal Chemistry Letters. 19: 3919-23. PMID 19349175 DOI: 10.1016/J.Bmcl.2009.03.072 |
0.662 |
|
| 2008 |
Dose C, Farkas ME, Chenoweth DM, Dervan PB. Next generation hairpin polyamides with (R)-3,4-diaminobutyric acid turn unit. Journal of the American Chemical Society. 130: 6859-66. PMID 18459783 DOI: 10.1021/Ja800888D |
0.667 |
|
| 2008 |
Chou CJ, Farkas ME, Tsai SM, Alvarez D, Dervan PB, Gottesfeld JM. Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia. Molecular Cancer Therapeutics. 7: 769-78. PMID 18413791 DOI: 10.1158/1535-7163.Mct-08-0130 |
0.501 |
|
| 2007 |
Hsu CF, Phillips JW, Trauger JW, Farkas ME, Belitsky JM, Heckel A, Olenyuk BZ, Puckett JW, Wang CC, Dervan PB. Completion of a Programmable DNA-Binding Small Molecule Library. Tetrahedron. 63: 6146-6151. PMID 18596841 DOI: 10.1016/J.Tet.2007.03.041 |
0.583 |
|
| 2007 |
Farkas ME, Tsai SM, Dervan PB. Alpha-diaminobutyric acid-linked hairpin polyamides. Bioorganic & Medicinal Chemistry. 15: 6927-36. PMID 17869122 DOI: 10.1016/J.Bmc.2007.07.019 |
0.563 |
|
| 2007 |
Nickols NG, Jacobs CS, Farkas ME, Dervan PB. Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface. Acs Chemical Biology. 2: 561-71. PMID 17708671 DOI: 10.1021/Cb700110Z |
0.717 |
|
| 2007 |
Nickols NG, Jacobs CS, Farkas ME, Dervan PB. Improved nuclear localization of DNA-binding polyamides. Nucleic Acids Research. 35: 363-70. PMID 17175539 DOI: 10.1093/Nar/Gkl1042 |
0.72 |
|
| 2007 |
Tsai SM, Farkas ME, Chou CJ, Gottesfeld JM, Dervan PB. Unanticipated differences between alpha- and gamma-diaminobutyric acid-linked hairpin polyamide-alkylator conjugates. Nucleic Acids Research. 35: 307-16. PMID 17170006 DOI: 10.1093/Nar/Gkl1025 |
0.527 |
|
| Show low-probability matches. |